Brefeldin A Solution (1,000X)

Pricing & Availability
Regulatory Status
RUO
Other Names
BFA
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Save
420601 1 mL ¥12,810
Description

Brefeldin A (BFA) is a protein transport inhibitor commonly used to enhance intracellular cytokine staining signals by blocking transport processes during cell activation. Especially useful for the intracellular staining of cytokines, BFA leads to the accumulation of most cytokines at the Golgi Complex/Endoplasmic Reticulum (see Jung, et al., 1993). Optimal conditions for use are cell type and time-dependent. Typically, protein transport inhibitors are included during in vitro cell activation cultures for 4-24 hours prior to harvest (see references below for additional information). Brefeldin A Solution is supplied as a 1,000X solution, which should be diluted to 1X in cell culture medium.

Product Details
Technical data sheet

Product Details

Formulation
Brefeldin A Solution is supplied as a 1000X in DMSO, which should be diluted to 1X in cell culture medium.
Concentration
5.0 mg/ml
Storage & Handling
Store the Brefeldin A Solution (1,000X) between 2°C and 8°C. Note: DMSO freezes at this temperature.
Application

ICFC - Quality tested

Recommended Usage

Dilute the 1000X solution to 1X in the tissue culture medium. It is recommended that cells are cultured with brefeldin A for ≤ 24 hours, as this can become toxic for cell viability.

Application Notes

Completely thaw the solution before use, DMSO freezes at 4°C.  We recommend aliquotting the reagent into smaller volumes to avoid repeated freeze-thawing.  

Application References

(PubMed link indicates BioLegend citation)
  1. O'Sullivan BJ, et al. 2006. J. Immunol. 176:7278.
  2. Fuse S, et al. 2007. J. Immunol. 178:5227.
  3. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  4. Redfern CH,et al.2006.J. Clin Oncol.19:3107. PubMed
  5. Smithey MJ, et al. 2008. J. Immunol. 180:3406. PubMed
  6. Elzey BD, et al. 2008. Blood 111:38684. PubMed
  7. Nguyen KD, et al. 2008. J. Immunol. 181:5386. PubMed
  8. Miner MD, et al. 2008. Microb Pathog. 45:273. PubMed
  9. Goodridge HS, et al. 2009. J. Immunol. 182:1146. PubMed
  10. Markey KA, et al. 2009. Blood 113:5644. PubMed
  11. Wilcox RA, et al. 2009. Blood PubMed
  12. Zenaro E, et al. 2009. J. Leukoc Bio. PubMed
  13. Rozkova D, et al. 2009. Clin Immunol. 131:1. PubMed
  14. Butcher JP, et al. 2010. Clin Cancer Res. 16:2065.
  15. Boisvert M, et al. 2010. J. Virol. 84:7782. PubMed
  16. Liu WC, et al. 2010. J. Virol. 84:12011.15. Tawara I, et al. 2011. Clin Cancer Res. 17:77. PubMed
  17. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  18. Schmidt NW, et al. 2011. J. Immunol. 186:3836. PubMed
  19. Langkjaer A, et al. 2012. Clin Immunol. 145:1. PubMed
  20. Molinero LL, et al. 2012. PNAS. 109:18529. PubMed
  21. Li HW, et al. 2012. J. Immunol. 189:5572. PubMed
  22. Wang JM, et al. 2013. J. Virol. 87:4372. PubMed
  23. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  24. Wang Jm, et al. 2013. J Virol. 87:11626. PubMed
  25. Lee TH, et al. 2013. J Biol Chem. 288:32873. PubMed
  26. Shi L, et al. 2014. J. Immunol. 192:649. PubMed
  27. Bulati M, et al. 2014. Exp Gerontol. PubMed
  28. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  29. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  30. Miller ML, et al. 2014. PNAS. 111:7397. PubMed
  31. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  32. Zhou GL, et al. 2014. J Cell Sci. 127:3916. PubMed
  33. Rist MJ, et al. 2015. J Virol. 89:703. PubMed
Product Citations
  1. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  2. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  3. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  4. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  5. Wang R, et al. 2018. Oncoimmunology. 7:e1461303. PubMed
  6. Yakkala C, et al. 2021. Front Immunol. 12:695150. PubMed
  7. Zheng B, et al. 2021. Int J Mol Sci. 22: . PubMed
  8. Alexander KL, et al. 2021. Gastroenterology. 161:522. PubMed
  9. Trinks N, et al. 2021. Commun Biol. 4:1151. PubMed
  10. Chen J, et al. 2022. Adv Healthc Mater. 11:e2101714. PubMed
  11. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  12. Pablo-Bernal R, et al. 2016. J Gerontol A Biol Sci Med Sci. 71: 610 - 618. PubMed
  13. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  14. Zhu S, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.10.013. PubMed
  15. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  16. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  17. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  18. Nesterenko PA, et al. 2021. Cell Rep. 37:110167. PubMed
  19. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  20. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  21. Fote GM, et al. 2022. J Cell Sci. 135:. PubMed
  22. Aguilar-Pineda JA, et al. 2021. iScience. 24:102993. PubMed
  23. Moudra A, et al. 2021. J Immunol. 206:2109. PubMed
  24. Shi L, et al. 2014. J Immunol. 192:649. PubMed
  25. Maschmeyer P, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.005. PubMed
  26. Yamamoto A, et al. 2019. J Clin Invest. 129:3640. PubMed
  27. Weng RR, et al. 2021. Nat Commun. 12:2163. PubMed
  28. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  29. Gay MD, et al. 2020. Cancer Prev Res (Phila). . PubMed
  30. Just S, et al. 2016. Sci Rep. 6:39796. PubMed
  31. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  32. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  33. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  34. Krone A, et al. 2022. Sci Rep. 218:. PubMed
  35. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  36. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  37. Starnbach X 2015. J Immunol. 195: 1665-1675. PubMed
  38. Garg B, et al. 2016. Mutagenesis. 10.1093/mutage/gew023. PubMed
  39. Ruhland M, et al. 2016. Nat Commun. 7:11762. PubMed
  40. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  41. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  42. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  43. Nguyen K, et al. 2008. J Immunol. 181:5386. PubMed
  44. Wilcox R, et al. 2009. Blood. 114:2936. PubMed
  45. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  46. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  47. Martens A, et al. 2020. Nat Immunol. 21:381. PubMed
  48. Wang Z, et al. 2020. Autophagy. 1:. PubMed
  49. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  50. Hradilova N, et al. 2017. PLoS One. 12(2):e0171539. PubMed
  51. Griffiths K, et al. 2016. Nat Commun. 7:13894. PubMed
  52. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  53. Al-Attar A, et al. 2016. Data Brief. 8: 536-44. PubMed
  54. Gonzalez-Perez G, et al. 2016. J Immunol. 196: 3768 - 3779. PubMed
  55. Pablo-Bernal R, et al. 2015. J Infect Dis. 10.1093/infdis/jiv520. PubMed
  56. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  57. Smithey M, et al. 2008. J Immunol. 180:3406. PubMed
  58. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  59. Dayoub O, et al. 2017. Sci Rep. 10.1038/s41598-017-09933-4. PubMed
  60. Kang X, et al. 2022. Vaccines (Basel). 10:. PubMed
  61. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  62. Jondle CN, et al. 2021. MBio. 12:. PubMed
  63. Doll K, et al. 2016. J Immunol. 196: 4253 - 4262. PubMed
  64. Liu W, et al. 2016. J Virol. 90: 6085 - 6096. PubMed
  65. Fucikova J, et al. 2016. Blood. 128(26):3113-3124. PubMed
  66. Douthwaite J, et al. 2017. J Immunol. 198(1):528-537. PubMed
  67. Yu H, et al. 2011. J Leukoc Biol. 90:205. PubMed
  68. Snyder LM, et al. 2022. Immunohorizons. 6:660. PubMed
  69. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  70. Rialdi A, et al. 2016. Science. 352: aad7993. PubMed
  71. Li H, et al. 2012. J Immunol. 189:5572. PubMed
  72. Liu W, et al. 2010. J Virol. 84:12011. PubMed
  73. Elzey B, et al. 2008. Blood. 111:3684. PubMed
  74. Ries M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006506. PubMed
  75. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  76. Codo AC, et al. 2020. Cell Metab. 32:437. PubMed
  77. Carissimo G, et al. 2019. Life Sci Alliance. 2:e201900298. PubMed
  78. Wang Y, et al. 2020. Sci Adv. 6:eaba5412. PubMed
  79. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  80. Shenoy AT, et al. 2021. Nat Commun. 12:5834. PubMed
  81. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  82. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  83. Dumaine JE, et al. 2021. Elife. 10:. PubMed
  84. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  85. Jondle CN, et al. 2021. J Virol. 95:e0072621. PubMed
  86. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  87. Uddin MN, et al. 2022. Brain Behav Immun Health. 26:100563. PubMed
  88. Gross C, et al. 2016. Neurol Neuroimmunol Neuroinflamm. 3: e289. PubMed
  89. Krämer B, et al. 2016. PLoS One. 11: 0162068. PubMed
  90. Tawara I, et al. 2011. Clin Cancer Res. 0.761805556. PubMed
  91. Orlov M, et al. 2017. PLoS One.. 10.1371/journal.pone.018296. PubMed
  92. Martins M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006529. PubMed
  93. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  94. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  95. Lee T, et al. 2013. J Biol Chem. 288:32873. PubMed
  96. Vigano S, et al. 2015. J Virol. 89: 7829-7840. PubMed
  97. Vacaflores A, et al. 2016. PLoS One. 11: 0157175. PubMed
  98. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  99. Kim J, et al. 2016. Nat Immunol. 17:1159-1166. PubMed
  100. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  101. Buqué A, et al. 2020. Nat Commun. 3.110416667. PubMed
  102. Cao Y, et al. 2018. Nat Commun. 2.940972222. PubMed
  103. Emmer BT, et al. 2018. Elife. 7:e38839. PubMed
  104. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  105. Harty N 2011. J Immunol. 186:3836. PubMed
  106. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  107. Yan H, et al. 2020. ACS Appl Mater Interfaces. 12:19324. PubMed
  108. Matisz C, et al. 2017. Sci Rep. 7:40631. PubMed
  109. Castro I, et al. 2016. J Virol. 90: 5280 - 5291. PubMed
  110. Zhang W, et al. 2015. Infect Immun . 83: 3213-3223. PubMed
  111. Ji L, et al. 2012. PLoS One. 7:e50909. PubMed
  112. Redfern C, et al. 2006. J Clin Oncol. 24:3107. PubMed
  113. Huang RS, et al. 2021. Curr Protoc. 1:e246. PubMed
  114. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  115. Gao Y, et al. 2022. Immunity. 55:1732. PubMed
  116. Han K, et al. 2021. Nat Metab. 3:318. PubMed
  117. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  118. Bachy S, et al. 2022. iScience. 25:103758. PubMed
  119. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  120. Wang J, et al. 2013. J Virol. 87:4372. PubMed
  121. Nice T, et al. 2016. PLoS One. 12: 1005684. PubMed
  122. Pfeifle R, et al. 2016. Nat Immunol. 18:104-113. PubMed
  123. Krishnan A, et al. 2020. Am J Pathol. 190:1284. PubMed
  124. Ngwenyama N, et al. 2019. JCI Insight. 4:e125527. PubMed
  125. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  126. Butchar J, et al. 2010. Clin Cancer Res. 2.100694444. PubMed
  127. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  128. Grace PS, et al. 2021. Front Immunol. 12:679973. PubMed
  129. Li Y, et al. 2021. Vaccines (Basel). 9:. PubMed
  130. Liu W, et al. 2022. Bio Protoc. 12:e4285. PubMed
  131. Ma K, et al. 2022. iScience. 25:104347. PubMed
  132. Loeuillard E, et al. 2020. J Clin Invest. 130:5380. PubMed
  133. Matsushita T, et al. 2015. Rheumatology. 101093/rumatology/kv331. PubMed
  134. Molinero L, et al. 2012. Proc Natl Acad Sci U S A. 109:18529. PubMed
  135. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  136. Sekine T, et al. 2020. Cell. 183:158. PubMed
  137. Gogokhia L, et al. 2019. Cell Host Microbe. 25:285. PubMed
  138. Guo C, et al. 2018. Immunity. 49:842. PubMed
  139. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  140. Rossato C, et al. 2017. Biologicals. 10.1016/j.biologicals.2017.06.007. PubMed
  141. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  142. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  143. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  144. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  145. Stepanova E, et al. 2021. Microorganisms. 9:. PubMed
  146. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  147. Langkjær A, et al. 2012. Clin Immunol. 145:1. PubMed
  148. Rozková D, et al. 2009. Clin Immunol. 131:1. PubMed
  149. Miner M, et al. 2008. Microb Pathog. 45:273. PubMed
  150. Miller M, et al. 2014. Proc Natl Acad Sci U S A. 111:7397. PubMed
  151. Gartlan K, et al. 2015. Blood. 126: 1609-1620. PubMed
  152. Ulland T, et al. 2016. Nat Commun. 7:13180. PubMed
  153. Melacarne A, et al. 2021. Cell Reports. 36(1):109312. PubMed
  154. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  155. Rosser EC, et al. 2020. Cell Metabolism. 31(4):837-851. PubMed
  156. Zenaro E, et al. 2009. J Leukoc Biol. 86:1393. PubMed
  157. Goodridge H, et al. 2009. J Immunol. 182:1146. PubMed
  158. Gnerlich J, et al. 2010. J Immunol. 185:4063. PubMed
  159. Boisvert M, et al. 2010. J Virol. 84:7782. PubMed
  160. Tse SW, et al. 2021. Mol Ther. 29:2227. PubMed
  161. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  162. Theisen U, et al. 2020. J Cell Biol. :219. PubMed
  163. Dáňová K, et al. 2017. J Immunol. 198(2):729-740. PubMed
  164. Beyaz S, et al. 2016. Nat Immunol. 18:184-195. PubMed
  165. Kadivar M, et al. 2016. J Immunol. 197(12):4584-4592. PubMed
  166. Wang J, et al. 2013. J Virol. 87:11262. PubMed
  167. Markey K, et al. 2009. Blood. 113:5644. PubMed
  168. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  169. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  170. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  171. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  172. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  173. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  174. Li Z, et al. 2021. JCI Insight. 6:. PubMed
  175. Virtakoivu R, et al. 2021. Clin Cancer Res. 27:4205. PubMed
  176. Koschel J, et al. 2021. Cell Death Differ. 28:2257. PubMed
  177. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  178. Bass VL, et al. 2021. Mol Syst Biol. 17:e10127. PubMed
  179. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  180. Bulati M, et al. 2014. Exp Gerontol. 54:123. PubMed
  181. Zhou G, et al. 2014. J Cell Sci. 127:3916. PubMed
  182. Rist M, et al. 2015. J Virol. 89:703. PubMed
  183. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  184. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  185. Mohammadpour H, et al. 2020. JCI Insight. 5:00. PubMed
  186. Landi A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.072. PubMed
  187. Gussarow D, et al. 2021. Front Med (Lausanne). 8:770381. PubMed
  188. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  189. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  190. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  191. Rau M, et al. 2016. J Immunol. 196: 97 - 105. PubMed
  192. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  193. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  194. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  195. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  196. Genardi S, et al. 2020. Front Immunol. 11:610010. PubMed
  197. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  198. Krishna B, et al. 2016. Sci Rep. 6: 24674. PubMed
  199. Schridde A, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.142. PubMed
  200. Wang W, et al. 2020. STAR Protoc. 1:100218. PubMed
  201. Ruland C, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.06.010. PubMed
  202. Ahmadi H,et al. 2017. Inflammopharmacology. . 10.1007/s10787-017-0410-8. PubMed
  203. Li J, et al. 2018. Redox Biol. 0.976388889. PubMed
  204. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  205. Laczkó D, et al. 2020. Immunity. 53:724. PubMed
  206. Abshire C, et al. 2016. PLoS Pathog. 12:e1006088. PubMed
  207. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  208. Lu G, et al. 2017. PLoS One. 12:e0178352. PubMed
  209. Orozco SL, et al. 2019. Cell Rep. 28:2275. PubMed
  210. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  211. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  212. Carrion B, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  213. Petrova T, et al. 2021. FEBS J. 288:5909. PubMed
  214. Nesterenko PA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  215. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.
5. Jung T, et al. 1993. J. Immunol. Meth. 159:197.

Gene ID
NA

Related FAQs

The Brefeldin A solution freezes at 4°C . Is the solution still OK?

We recommend to thaw in warm water after removing from the fridge.  The Brefeldin A is dissolved in DMSO, which freezes at 18°C, so this is normal.  No one has reported any problems with the freeze/thaw cycles and this is how we recommend it is stored.   If customers are concerned, they can aliquot the Brefeldin A to avoid the freeze thaw.

How do I choose monensin or Brefeldin A solution?

Generally, Brefeldin A is more toxic for longer term incubations, so for shorter stimulations (6 hrs or less) use Brefeldin A.  For longer stimulations use monensin.  We recommend optimization for each cell type and protocol.

Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account